CONNECT WITH US
Fintech

Fintech

Apple and OpenEvidence Seek 200,000 Consumers for Health AI Study

PYMNTS – Fintech logo

Published on

Add as a preferred source on Google
Apple and OpenEvidence Seek 200,000 Consumers for Health AI Study

Apple has launched a virtual research study and an associated app to look at how people use conversational artificial intelligence tools for health, the company said in a Sunday (Nov. 15) press release.

Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

With the Apple Health AI Usage Study, Apple aims to support the design of health AI experiences by examining what drives user trust, the quality of responses, comprehension and everyday health actions, according to the release.

“Insights from this study will help advance the broader scientific conversation and ensure that as technology evolves, we continue building trusted tools that genuinely support people wherever they are on their health journey,” Sumbul Desai, M.D., vice president of health and fitness at Apple, said in the release.

Apple is conducting the study with OpenEvidence, a clinical AI platform that is widely used by healthcare professionals and that generates answers using medical information from established sources, according to the release.

Participants in the study will be able to ask the study app questions about health and will be invited to share their HealthKit metrics to explore how personal data integration impacts relevance and understanding, the release said.

The Apple Health AI Usage Study is open to up to 200,000 eligible participants age 21 and older across the United States, per the release.

OpenEvidence CEO Daniel Nadler said in a Sunday post on X: “OpenEvidence is the most trusted and loved brand product among doctors.


Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.